Recent news highlights a decline in fiscal 2026 earnings due to structural sales weakness, with quarterly earnings showing variability influenced by cost management and sector demand.

• Taylor Devices reported a 26% decrease in net sales and a 79% decrease in net income for the quarter ended August 31, 2026, attributed to structural sales weakness and timing differences in bookings and backlog conversion [N1][S2].
• The company’s backlog increased to $55.2 million as of August 31, 2026, up from $52.8 million a year earlier, indicating a solid order pipeline [S2].
• Q3 earnings increased year-over-year due to lower costs, while Q4 income retreated reflecting sales declines and margin pressure [N3][N2].
• Sales to aerospace/defense customers decreased 17% year-over-year in the latest quarter, while industrial customer sales increased 8% [S2].
• Research and development expenses increased 88% year-over-year in the latest quarter, reflecting increased investment [S2].
• Selling, general and administrative expenses decreased 7% year-over-year due to lower employee incentive compensation accruals [S2].
• Operating income declined 98.3% year-over-year in the latest quarter due to lower gross margin and sales mix shifts [S2].
• Other income increased 9% year-over-year driven by short-term investment interest income [S2].

Taylor Devices’ backlog growth and strong liquidity position provide a foundation for operational stability. Increased research and development spending may support product innovation and competitiveness. The company’s diversified customer base across industrial, structural, and aerospace/defense sectors offers multiple revenue streams. Capacity expansion plans indicate management’s intent to support future demand. Cost management efforts have led to reduced selling, general and administrative expenses, partially offsetting sales declines.

The company faces structural sales weakness, particularly in aerospace/defense and construction sectors, leading to significant declines in net sales and operating income. Fluctuations in backlog conversion and project timing create revenue volatility. Lower gross margins and shifts in sales mix have pressured profitability. Increased inventory levels and longer days sales outstanding may impact working capital efficiency. Capital expenditure commitments add to financial obligations amid uncertain demand. Dependence on fixed-price contracts exposes the company to risks of contract losses if costs escalate.

Taylor Devices benefits from a specialized product portfolio serving niche industrial, structural, and aerospace/defense markets, supported by long-term contracts and a substantial backlog. The company’s ability to secure fixed-price contracts with enforceable payment rights and its backlog visibility provide some operational stability. Its liquidity position and investment in capacity expansion support ongoing operations. However, the company faces exposure to fluctuations in project timing and sector demand, which can impact revenue and profitability.

• Sales Concentration and Market Fluctuations: Significant sales exposure to aerospace/defense and structural sectors subjects the company to demand volatility and timing risks affecting revenue and backlog conversion.
• Contract and Project Execution Risks: Fixed-price contracts with revenue recognized over time carry risks of cost overruns and potential losses if project costs exceed estimates.
• Inventory and Working Capital Management: Rising inventory levels and increased days sales outstanding may strain liquidity and operational efficiency.
• Profitability Pressure: Declining gross margins and shifts in sales mix have materially reduced operating income, challenging profitability sustainability.
• Capital Expenditure Commitments: Planned capital expenditures for capacity expansion increase financial commitments amid uncertain market conditions.

• Taylor Devices, Inc. manufactures and sells products primarily to industrial, structural, and aerospace/defense customers.
• The company recognizes revenue on certain fixed-price contracts over time based on cost-to-total estimated cost ratio, with adjustments for estimated losses or profits on contracts in progress.
• For the quarter ended August 31, 2026, net sales decreased 26% year-over-year to $7.3 million, with a 51% decrease in gross profit and a 79% decrease in net income compared to the same period in 2025.
• Sales decreased across aerospace/defense (-17%) and construction of buildings and bridges (-49%) but increased to industrial customers by 8% in the quarter ended August 31, 2026.
• The company had 24 long-term projects in process during the quarter ended August 31, 2026, compared to 25 in the prior year period.
• Backlog increased to $55.2 million as of August 31, 2026, from $52.8 million at the prior year-end, including a $19.0 million non-project order with deliveries scheduled through fiscal 2030.
• The backlog includes 151 open sales orders as of August 31, 2026, up from 127 a year earlier.
• The company’s liquidity position as of August 31, 2026, includes $3.6 million in cash and equivalents and $45.5 million in short-term investments, with a current ratio of 8.66 and a cash ratio of 6.43.
• Research and development expenses increased 88% year-over-year for the quarter ended August 31, 2026, to $152,000, representing 2.1% of net sales.
• Selling, general and administrative expenses decreased 7% year-over-year to $1.97 million for the quarter ended August 31, 2026, primarily due to lower employee incentive compensation accruals.
• Operating income for the quarter ended August 31, 2026, was $38,000, down 98.3% from $2.25 million in the prior year period, reflecting lower gross margin and sales mix shifts.
• Other income increased 9% year-over-year to $418,000 for the quarter ended August 31, 2026, driven by short-term investment interest income.
• Inventory increased 24% year-over-year to $9.36 million as of August 31, 2026, with 88% classified as work-in-process.
• Accounts receivable decreased 14% year-over-year to $3.37 million as of August 31, 2026, net of a $195,000 allowance for credit losses.
• The company’s days sales outstanding in accounts receivable increased slightly from 40 to 42 days between May 31, 2026, and August 31, 2026.
• The company’s backlog and revenues fluctuate period to period and are influenced by timing of bookings and backlog conversion to revenue.
• Capital expenditures were $242,000 for the quarter ended August 31, 2026, with commitments totaling $1.93 million for the next twelve months, including evaluation of additional capacity expansion.
• The company’s sales are primarily domestic (89% of net sales for the quarter ended August 31, 2026) with 9% to Asia and 2% to other regions.
• The company’s financial figures are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.